Local leaders address Ebola concerns - Amarillo.com

If a person begins to feel flu-like symptoms, there are two factors that point to Ebola: Travel to one of the four West African countries currently affected and direct contact with the bodily fluids of an Ebola-infected individual.

...

Dr. Roger Smalligan, public health authority for Potter and Randall counties and chairman of internal medicine at Texas Tech University Health Sciences Center in Amarillo, said an infected person’s tears, saliva, semen, nasal and vaginal secretions, blood or anything else liquid that comes from the body would have the virus in it, but only if that person is actively symptomatic.

Read the full story >>

Related Stories

Willed Body Memorial Service Honors Those Who Donated

On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.

Molecular Pathology Preceptorship: Unmatched Value and Experience

Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.

Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing

Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.

Recent Stories

Research

TTUHSC Researcher Receives National Award

The AACR presented its Minority-Serving Institution Faculty Scholar in Cancer Research Award to TTUHSC Associate Professor Duke Appiah, Ph.D., MPH, at the AACR 2025 Annual Meeting in Chicago recently.

Research

TTUHSC Teams Selected for 2025 Innosphere Life Sciences Accelerator Cohort

A pair of teams representing TTUHSC earned a spot among the 33 startup groups selected for the 2025 cohort of the Innosphere Life Sciences Accelerator.

Research

Exploring New Frontiers in Patient Care

Jenna Kesey, Ph.D., associate managing director for the Clinical Research Institute (CRI) at TTUHSC, said it's important that the university provides opportunities for its patients to have access to innovative therapies through the clinical trial process.